Welcome Guest
Home > Clinical Genitourinary Cancer > Volume 2 |  Issue 1

Table of Contents

Volume 2 |  Issue 1

Publication Date: June 2003
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorial
Page Number of this Article in the Print Version
5-6		 Rising Prostate-Specific Antigen After Local Therapies Have Failed: An Urgent Need for More Information
Oliver Sartor
  • Abstract
  • No Access
  • Add to Cart
Meeting Highlights
Page Number of this Article in the Print Version
8-12		 Highlights from: The 98th Annual Meeting of the American Urological Association; Chicago, IL; April 26–May 1, 2003
Heather DeGrendele, Jennifer Klem, Mary Hightower, Michael P. Kosty, Oliver Sartor
  • Abstract
  • No Access
  • Add to Cart
Researches in Brief
Page Number of this Article in the Print Version
13-14		 High Androgen-Receptor Levels are Predictive of Decreased Survival in Prostate Cancer
David Lee, William Oh, Oliver Sartor
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
15-17		 Radical Prostatectomy Improves Cancer-Specific Survival But Not Overall Survival in Early-Stage Prostate Cancer
David Lee, William Oh, Oliver Sartor
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Review
Page Number of this Article in the Print Version
18-21		 Changes in Body Composition During Hormonal Therapy for Prostate Cancer
Matthew R. Smith
  • Abstract
  • No Access
  • Add to Cart
Commentary
Page Number of this Article in the Print Version
22-23		 Androgen-Deprivation Therapy for Prostate Cancer
Celestia Higano
  • Abstract
  • No Access
  • Add to Cart
Original Contribution
Page Number of this Article in the Print Version
24-31		 Phase IIA Clinical Trial to Test the Efficacy and Safety of Toremifene in Men with High-Grade Prostatic Intraepithelial Neoplasia
Mitchell S. Steiner, Charlie R. Pound
  • Abstract
  • No Access
  • Add to Cart
Commentary
Page Number of this Article in the Print Version
32-33		 Models for Prostate Cancer Chemoprevention
Glenn Bubley
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
34-40		 Management of Vertebral Metastases in Prostate Cancer: A Retrospective Analysis in 119 Patients
Luis E. Cereceda, Aude Flechon, Jean-Pierre Droz
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
41-45		 Ten-Year Survival in Patients with Metastatic Prostate Cancer
Catherine M. Tangen, James R. Faulkner, E. David Crawford, Ian M. Thompson, Daisaku Hirano, Mario Eisenberger, Maha Hussain
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
46-49		 Biweekly Administration of Low-Dose Docetaxel in Hormone-Resistant Prostate Cancer: Pilot Study of an Effective Subtoxic Therapy
Vasilis Karavasilis, Evangelos Briasoulis, Olga Siarabi, Nicholas Pavlidis
  • Abstract
  • No Access
  • Add to Cart
Translational Medicine
Page Number of this Article in the Print Version
50-57		 Involvement of Growth Factor Receptors of the Epidermal Growth Factor Receptor Family in Prostate Cancer Development and Progression to Androgen Independence
Giuseppe Di Lorenzo, Roberto Bianco, Giampaolo Tortora, Fortunato Ciardiello
  • Abstract
  • No Access
  • Add to Cart